SUNPHARMA.NS Balance Sheet
Sun Pharmaceutical Industries Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-24 01:42
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹103.90 Bn | ₹101.92 Bn | ₹100.36 Bn | ₹111.14 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹9.63 Bn | ₹11.08 Bn | ₹12.34 Bn | ₹13.81 Bn | CapitalWorkInProgress |
| Goodwill | ₹87.13 Bn | ₹85.99 Bn | ₹89.39 Bn | ₹98.33 Bn | Goodwill |
| Other Intangible Assets | ₹53.17 Bn | ₹44.20 Bn | ₹36.11 Bn | ₹118.75 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹50.68 Bn | ₹59.99 Bn | ₹42.49 Bn | ₹37.89 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹26.79 Bn | ₹27.59 Bn | ₹9.61 Bn | ₹11.16 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹408.60 Bn | ₹419.88 Bn | ₹394.76 Bn | ₹448.94 Bn | NoncurrentAssets |
| Inventories | ₹105.13 Bn | ₹98.68 Bn | ₹102.43 Bn | ₹114.93 Bn | Inventories |
| Trade Receivables | ₹114.39 Bn | ₹112.49 Bn | ₹130.46 Bn | ₹155.10 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹46.24 Bn | ₹92.86 Bn | ₹102.69 Bn | ₹97.71 Bn | CashAndCashEquivalents |
| Current Investments | ₹93.73 Bn | ₹85.85 Bn | ₹136.56 Bn | ₹209.33 Bn | CurrentInvestments |
| Other Current Assets | ₹19.62 Bn | ₹22.28 Bn | ₹25.28 Bn | ₹28.65 Bn | OtherCurrentAssets |
| Total Current Assets | ₹398.62 Bn | ₹434.33 Bn | ₹525.94 Bn | ₹638.60 Bn | CurrentAssets |
| Total Assets | ₹807.44 Bn | ₹854.63 Bn | ₹921.01 Bn | ₹1,087.85 Bn | Assets |
| Equity Share Capital | ₹2.40 Bn | ₹2.40 Bn | ₹2.40 Bn | ₹2.40 Bn | EquityShareCapital |
| Other Equity | ₹557.55 Bn | ₹634.27 Bn | ₹719.78 Bn | ₹833.30 Bn | OtherEquity |
| Equity Attributable to Owners | ₹559.95 Bn | ₹636.67 Bn | ₹722.18 Bn | ₹835.70 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹33.20 Bn | ₹34.39 Bn | ₹2.68 Bn | ₹3.10 Bn | NonControllingInterest |
| Total Equity | ₹593.15 Bn | ₹671.06 Bn | ₹724.86 Bn | ₹838.80 Bn | Equity |
| Long-term Borrowings | ₹0.00 Bn | ₹0.01 Bn | ₹0.03 Bn | ₹0.31 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹15.21 Bn | ₹13.73 Bn | ₹14.20 Bn | ₹22.83 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹61.98 Bn | ₹28.44 Bn | ₹18.67 Bn | ₹40.50 Bn | BorrowingsCurrent |
| Trade Payables | ₹56.82 Bn | ₹56.53 Bn | ₹61.84 Bn | ₹73.34 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹6.43 Bn | ₹10.84 Bn | ₹11.70 Bn | ₹11.88 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹199.06 Bn | ₹169.84 Bn | ₹181.94 Bn | ₹226.22 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹807.44 Bn | ₹854.63 Bn | ₹921.01 Bn | ₹1,087.85 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from SUNPHARMA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).